Heart Blood Flow Measurement: SYN2 PET Imaging

We are testing a new imaging method to measure blood flow in the heart for patients suspected of having coronary artery disease. The study aims to ensure this method is accurate and safe for use.

1-2 years ≤5 visits Efficacy phase (II)No Placebo Investigational Medicines InjectionCardiologyInternal Medicine

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Rapiscan

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Adenosine

Adenosine is a substance that quickly restores normal heart rhythm during certain types of rapid heartbeats.

Regadenoson

Regadenoson is a substance used during heart stress tests to temporarily increase blood flow and help detect coronary artery blockages.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Syn2

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Swietokrzyskie Centrum Onkologii Samodzielny Publiczny Zaklad Opieki Zdrowotnej W Kielcach

Zakład Medycyny Nuklearnej z Ośrodkiem PET

Kielce, Poland

Affidea Sp. z o.o.

Affidea PET/CT Warszawa

Praga Południe, Poland

Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy

Zakład Medycyny Nuklearnej

Praga Południe, Poland

Sponsor: Synektik S.A.

Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.